Labcorp (LH) Tops Q3 EPS by 1c; Offers FY22 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Labcorp Announces 2022 Third Quarter Results
October 27, 2022 7:00 AM EDTCompany Updates Full-Year GuidanceÂ
Revenue: Q3 of $3.6 billion versus $4.1 billion last year Diluted EPS: Q3 of $3.90 versus $6.05 last year Adjusted EPS: Q3 of $4.68 versus $6.82 last year Free Cash Flow: Q3 of $270 million versus $650 million last year Progressed Clinical Development business spin-off activities Completed transactions to establish long-term relationship with AscensionÂ
BURLINGTON, N.C.--(BUSINESS WIRE)-- Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022, and updated full-year... More
